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Abstract
Background: Recent studies suggest that alterations in expression of genes, including those which regulate neural and
structural plasticity, may be crucial in the pathogenesis of depression. MicroRNAs (miRNAs) are newly discovered regulators
of gene expression that have recently been implicated in a variety of human diseases, including neuropsychiatric diseases.
Methodology/Principal Findings: The present study was undertaken to examine whether the miRNA network is altered in
the brain of depressed suicide subjects. Expression of miRNAs was measured in prefrontal cortex (Brodmann Area 9) of
antidepressant-free depressed suicide (n=18) and well-matched non-psychiatric control subjects (n=17) using multiplex
RT-PCR plates. We found that overall miRNA expression was significantly and globally down-regulated in prefrontal cortex of
depressed suicide subjects. Using individual tests of statistical significance, 21 miRNAs were significantly decreased at
p=0.05 or better. Many of the down-regulated miRNAs were encoded at nearby chromosomal loci, shared motifs within the
59-seeds, and shared putative mRNA targets, several of which have been implicated in depression. In addition, a set of 29
miRNAs, whose expression was not pairwise correlated in the normal controls, showed a high degree of co-regulation
across individuals in the depressed suicide group.
Conclusions/Significance: The findings show widespread changes in miRNA expression that are likely to participate in
pathogenesis of major depression and/or suicide. Further studies are needed to identify whether the miRNA changes lead
to altered expression of prefrontal cortex mRNAs, either directly (by acting as miRNA targets) or indirectly (e.g., by affecting
transcription factors).
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Introduction
Depression is a major public health concern. Despite many
years of research, the molecular and cellular mechanisms
associated with depression are not clear. Recent studies suggest
that alterations in expression of genes, including those which
regulate neural and structural plasticity, may be crucial in the
pathogenesis of depression [1,2]. In the past few years, it has
become clear that besides the traditional transcriptional mecha-
nisms (e.g., by transcription factors and alternative splicing), gene
expression is also regulated by a variety of noncoding RNA
transcripts that generate antisense RNAs, microRNAs (miRNAs),
and other small RNAs, which are linked to several post-
transcriptional and epigenetic mechanisms. Of these, the best
investigated are the microRNAs, which were first identified as
regulators of developmental timing and cell fate, and later were
found to comprise a population of hundreds of distinct genes that
are widely expressed in nearly all multicellular organisms and in
many tissues, including adult mammalian brain.
The miRNAs are encoded within primary miRNA gene
transcripts (pri-miRs) that may be intergenic (away from known
protein-coding genes) or located within introns of protein-coding
host genes [3,4]. Pri-miRs are transcribed by pol II, may be
spliced, and may acquire a poly-A+ tail; they are then processed
further within the nucleus by Drosha and other co-factors to form
one or a series of ,70–110 nt. small hairpin miRNA precursors,
or (pre-miRs) that fold into a stem-loop structure. The pre-miRs
are transported out of the nucleus and processed by Dicer to form
a double-stranded small RNA about 22 nt. long. Generally, one of
these strands is preferentially incorporated into a complex with
one or more Argonaute homolog proteins (isoforms of eIF2c).
Thus, one has a single-stranded mature miRNA of ,22 nt. in
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such as FMRP, comprises the so-called RISC complex. The RISC
complex binds to specific ‘‘short seed’’ sequences located
predominantly within the 39-UTR region of mRNAs, which can
interfere with translation and/or stability of the mRNA. Besides
the direct sequence-specific interaction of RISC with mRNAs,
other proteins that bind nearby sites within the 39-UTR (e.g.,
FMRP homologues, HuB family members and other ARE binding
proteins) may control the magnitude of miRNA effects. Indeed, in
certain situations, miRNAs may actually enhance rather than
inhibit translation [5]. MiRNAs can also inhibit or stimulate
transcription of certain genes [6]. miRNAs tend to act in co-
regulated groups, and to affect groups of targets as part of larger
gene expression networks that contain feedback and feedforward
regulatory loops [7].
There is emerging evidence that miRNAs can contribute to risk
of neuropsychiatric disorders, particularly Huntington disease
[8,9], Parkinson disease [10,11], and Tourette’s syndrome [12].
Recently, several studies have reported altered levels of specific
miRNAs in postmortem brain of subjects who died with a
diagnosis of schizophrenia [13,14,15,16]. These changes did not
appear to be secondary to neuroleptic treatment [14]. As well, in a
case-control study, single nucleotide polymorphic analysis identi-
fied two brain-expressed miRNAs as being linked to schizophrenia
[17]. So far, there is no direct study examining the role of brain
miRNA in mood disorders; however, it has been shown that stress,
glucocorticoids and mood-stabilizers modulate expression of
selective miRNAs [18]. In recent studies of mouse olfactory
discrimination training [19] and the learned helpless model of
behavioral depression [20], we observed that many miRNAs
exhibited a wide range of expression values across individuals
and were dynamically sensitive to environmental, sensory and
contextual cues. The present study comprehensively examines
miRNA expression analysis in depressed suicide subjects. The PFC
plays a relevant role in mood regulation and has been associated
with a number of neurobiological abnormalities implicated in the
pathophysiology of depression and suicide [21,22].
Materials and Methods
Tissue Preparation
The study was approved by the institutional review board of the
University of Illinois at Chicago. Tissues were obtained from the
Quebec Suicide Brain Bank. The activities of the Quebec Suicide
Brain Bank are approved by the Douglas Hospital McGill
University IRB. Family members/informants signed written
informed consents. For identification and dissection of neuroan-
atomical regions, we relied on experienced histopathologists using
reference neuroanatomical maps [23]. Gyri and sulci were used to
landmark specific frontal cortical areas. More precisely, the frontal
lobes were sliced into 1–1.5 mm thick coronal sections. The
dorsomedial PFC (Brodmann’s area 9) was taken just dorsal to the
frontopolar area including the most polar portion of the superior
and partly the middle superior gyrus between the superior and
intermediate frontal sulci. In the sections of the dissected cortical
area, the gray and white matters were separated and the gray
matter was used in this study. All the tissues were screened for
evidence of neuropathology by experienced neuropathologists. pH
of the brain was measured in cerebellum in all cases as described
by Harrison et al. [24].
Diagnosis
Psychiatric diagnoses of subjects were made by means of the
psychological autopsy method. This technique, which has been
validated for Axis I and II diagnoses [25,26] consists in part of
selecting a family member who is best acquainted with the
deceased to serve as an informant and undergo the interview
process. Informants included primarily mother, father, siblings,
and significant other friends, or relatives. In our previous studies,
the type of informant made no significant difference in rating the
specific disorders identified [27]. Families are recruited at the
Montreal Morgue and are interviewed, on average, 4 months after
the death. The activities of the Quebec Suicide Brain Bank are
approved by the Douglas Hospital McGill University IRB. Family
members/informants sign written informed consents. Psychiatric
diagnoses are obtained using the SCID [28] interview for axis I
DSM-IV diagnoses, as well as the SCID II. Family members are
requested to give written permission for clinical records to be
obtained from prior mental health treatment providers. An
attempt is made to collect all available records on each case,
and then the appropriate data are extracted from the records and
collected. Information collected through SCID I and II interviews
and from the Coroner’s notes and medical records is used by
interviewers to write a case history for each subject. These case
histories are then reviewed by a clinical panel, in order to reach a
consensus DSM-IV diagnosis for each subject. All normal controls
are verified as being free of mental illness by the same diagnostic
process. Inter-rater reliability is routinely checked and periodic
interviewer retraining is performed to avoid drifting. Toxicology
screening for alcohol, a comprehensive battery for illicit drug use,
and screening for antidepressant or psychoactive drugs taken prior
to death were performed in blood/urine of each subject. Subjects
were negative for all the toxicology screens. Characteristics of
normal controls and suicide subjects are provided in Table 1.
There were no significant differences in age, PMI, or pH of the
brain between depressed suicide and normal control subjects.
RNA Isolation
Total RNA was isolated in samples of prefrontal cortex
(Brodmann Area 9) using a modified protocol designed to
optimize recovery of small RNAs [29]. Total RNA was isolated
with Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA,
USA) according to manufacturer’s directions with a few
modifications to maximize yield of small RNAs. Glycoblue
20 mg (Ambion) was added to the RNA precipitation step which
was allowed to proceed overnight at 220uC. The RNA pellet was
spun down at 20,000 g for 25 min at 4uC; rinsed with 80%
ethanol in DEPC-treated water (Invitrogen Life Technologies,
Carlsbad, CA, USA); resuspended and treated with RNAsecure
(Ambion); and treated with DNase I using DNA-free (Ambion).
RNA was treated with DNAse I and checked for purity by OD
260/280 ratio (NanoDrop 1000 spectrophotometer, Thermo-
scientific, Wilmington, DE, USA). The quality of total RNA was
verified for all subjects by running on agarose gels. Quality of total
RNA was also checked by determining RNA integrity number
(RIN) and only samples showing RIN.8.5 were included.
miRNA Analysis
Reverse transcription was performed with the TaqManH
miRNA Reverse Transcription kit (ABI: Applied Biosystems)
and the multiplex RT for TaqManH miRNA Assays (ABI) that
consists of eight predefined reverse transcription primer pools
(ABI) following the manufacturer’s protocol. For each RT pool,
100 ng of total RNA was used and the product was diluted 1:62.5
and 55 ml mixed with 55 ml of TaqManH Universal PCR Master
Mix, No AmpEraseH UNG. 100 ml of each mix was dispensed in
the appropriate well in the TaqManH Human miRNA Array v1.0
(TLDA, ABI) and run to 50 cycles as per manufacturer’s protocol
miRNA and Depression
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suicide samples were processed and assayed on the same day, by
an individual who was unaware of group identity. A sample
processed without reverse transcription showed no detectable
miRNA values.
Using 4 samples run on duplicate plates to monitor inter-plate
reliability, we observed that Ct values above 35 were markedly less
reliable, and so Ct=35 was set as the threshold of detectability.
Four data points were removed as outliers (defined as measure-
ments that were at least 3 SD different than all other
measurements of the same miRNA; in all cases, there was no
more than one outlier observed for a single miRNA); however,
removal of outliers did not affect the results reported here. Ct
values were normalized using U6 RNA, whose mean value did not
vary across groups and showed low variability. In the first 15
samples in each group, exogenous synthetic mir-122a was spiked
Table 1. Characteristics of subjects in the depressed suicide and normal control groups.
Subject No. Age (y) Sex PMI (h) Brain pH RIN Cause of Death
Depressed Suicide Group
1 40 Male 24 6.2 9.1 Hanging
2 19 Male 29 6.3 9.2 Hanging
3 53 Male 29 6.3 9.0 Hanging
4 35 Male 30 6.7 8.9 Hanging
5 39 Male 15 6.6 9.1 Hanging
6 22 Male 11 6.4 9.3 Hanging
7 49 Male 30 6.6 9.1 Hanging
8 26 Male 34 6.7 8.88 Hanging
9 40 Male 22 6.7 9.2 Hanging
10 18 Male 27 6.8 9.2 CO poisoning
11 38 Male 20 6.6 8.7 Hanging
12 48 Male 15 6.6 9.2 Hanging
13 22 Male 24 6.8 8.8 Jumped
14 55 Female 36 6.5 9.3 Hanging
15 38 Male 40 6.4 8.8 Intoxication
16 65 Female 40 6.5 8.7 Jumped
17 51 Male 46 6.4 8.7 Intoxication
18 63 Male 50 6.4 8.5 Hanging
Mean 40.0 29 6.5 8.98
SD 14.6 10.7 0.2 0.24
Control Group
29 31 Male 26 6.0 9.0 Cardiac arrest
30 19 Male 32 6.6 8.7 Car accident
31 47 Male 24 6.5 9.1 Cardiac arrest
32 30 Male 30 6.4 9.3 Cardiac arrest
33 28 Male 27 6.3 9.2 Car accident
34 41 Male 24 6.0 9.0 Cardiac arrest
35 31 Male 28 6.7 9.1 Car accident
36 32 Male 26 6.7 9.3 Drug overdose
37 46 Male 21 6.6 8.7 Cardiac arrest
38 21 Male 46 6.4 9.0 Cardiac arrest
39 27 Male 25 6.4 8.6 Cardiac arrest
40 32 Male 27 6.7 9.2 Cardiac arrest
41 45 Male 27 6.6 9.0 Cardiac arrest
42 15 Male 27 6.6 9.1 Accidental death
43 38 Male 30 6.8 8.6 Natural death
44 57 Male 25 6.7 9.1 Accidental death
45 63 Male 13 6.5 9.1 Accidental death
Mean 35.5 26.9 6.5 9.01
SD 13.0 6.4 0.2 0.22
doi:10.1371/journal.pone.0033201.t001
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check for possible differences in sample yield, integrity or loading;
results were similar whether normalizing to the endogenous (U6)
or exogenous (mir-122a) RNA. Note that Ct values cannot be
compared directly across different miRNAs, but when comparing
the same miRNA in different samples, a higher Ct value indicates
lower abundance, and a difference in Ct values of 1 indicates a
two-fold difference in abundance.
Western Blot Analysis of Target Proteins DNMT3b, BCL2,
and VEGFA
Tissues were homogenized on ice with a glass-Teflon homog-
enizer in lysis buffer (50 mM Tris–hydrogen chloride, pH 7.5,
100 mM sodium chloride, 1% Triton X-100, 50 mM sodium
fluoride, 10 mM sodium phosphate, 5 mM EDTA, 1 mg/mL
aprotinin, 1 mg/mL leupeptin, 1 mM sodium orthovanadate, and
1 mM 4-[2-aminoethyl] benzenesulfonyl fluoride hydrochloride).
The homogenates were centrifuged at 14,000 g for 10 minutes.
The protein content in the supernatant was determined by the
Bradford method (Bio-Rad, Hercules, CA).
Samples containing equal amount of protein (30 mg) were
resolved onto 10% (wt/v) sodium dodecyl sulfate (SDS)–poly-
acrylamide gel and blotted on an enhanced chemiluminescence
(ECL) membrane (Amersham) as described earlier (30). Mem-
branes were incubated with human-specific DNMT3b (LifeSpan
Bio, Seattle, WA), BCL2 (Abcam, San Francisco, CA), or VEGFA
(LifeSpan Bio, Seattle, WA) antibody overnight at 4uC. The
dilution for each antibody was as follows: DNMT3b, 1:500; BCL2,
1:1000; VEGFA 1:1000. The ECL membranes were then
incubated with horseradish peroxidase–linked secondary antibody
(anti-mouse or anti-rabbit IgG, 1:1000) for 5 hours at room
temperature and exposed to ECL autoradiography film. Mem-
branes were stripped and reprobed with endogenous protein b-
actin antibody (Sigma Chemical Co, St. Louis, MO) as described
earlier [30]. The optical densities of the bands were quantified
using the Loats Image Analysis System (Loats Associates, Inc,
Westminster, MD). Ratios of optical densities of DNMT3b, BCL2,
or VEGFA to b-actin were calculated. DNMT3b, BCL2, and
VEGFA migrated to 96, 26, and 22 kDa, respectively. Immuno-
labeling of b-actin was not significantly different in depressed
subjects (1.160.2 AU) compared with normal controls (1.260.2
AU).
The specificity of DNMT3b, BCL2, and VEGFA antisera were
checked by using a 100-fold excess of blocking peptide (relative to
the molarity of the antisera) corresponding to the epitope used to
generate DNMT3b, BCL2, and VEGFA. In addition, to validate
our data, we initially determined the immunolabeling of
DNMT3b, BCL2, and VEGFA in the PFC of depressed suicide
and control subjects using 5 different concentrations of protein (5–
50 mg). It was observed that the optical density of the band
increased linearly with increased concentration of protein and that
the curve shifted toward the right when a decrease in
immunolabeling was observed (data not shown).
Statistical Analysis
The non-parametric Wilcoxon sign-rank test, 2-tailed was
utilized when making lists of miRNAs whose mean expression
levels differed significantly across treatment groups, since this test
is appropriate for all miRNAs whether or not they follow a normal
distribution [31]. The Bonferroni correction of statistical signifi-
cance values was not appropriate in this study because it assumes
that the expression of the vast majority of genes is independent of
each other. This situation does not apply in the case of miRNAs,
which form extensive cross-correlation networks –in some cases
due to co-transcription from the same primary gene transcripts
[29,32], and in some cases due to shared factors that co-regulate
their expression within a given tissue or even within a disease
condition (see Results). Instead, we performed SAM analysis
(Significance Analysis of Microarrays software, version 3.08,
Stanford University, http://www-stat.stanford.edu/,tibs/SAM/),
which estimated statistical significance by subjecting the data to
multiple random permutations; parameters were set for two-class
unpaired analysis, Wilcoxon statistic and 5000 permutations.
To measure possible correlations between miRNAs and age,
postmortem interval and pH, the latter factors were converted to
log2 scores to be comparable with Ct values, and all miRNAs were
tested for correlations with each factor across all 35 samples. Given
the total sample size (n=35), a correlation of r=0.333 is
significantly different from r=0 at the p=0.05 significance level.
The protein levels of DNMT3b, BCL2, and VEGFA were
compared between depressed suicide and normal controls using
independent sample t-test. The correlations between protein levels
of DNMT3b, BCL2, and VEGFA and corresponding miRNAs
were calculated using Pearson product-moment correlation
analysis.
Target Prediction
Despite active research in the miRNA field, it is currently not
possible to predict accurately which individual brain-expressed
mRNAs are most likely to be targeted by a given miRNA [33].
However, we attempted to glean further insights by combining
evidence from 11 miRNA target prediction servers using the
miRecords meta-server [34]. For each down-regulated miRNA,
the meta-server was queried to identify targets that are predicted
by at least 3 different prediction servers, and the top 30 ranked
targets were tabulated (this is a small fraction of the total number
of predictions). We then asked whether certain targets of potential
interest were common to many different miRNAs in the down-
regulated set of 37 miRNAs listed in Table 2.
mRNA levels of Dicer, Drosha, DGCR8, and pri-miRs 155
and 494
Total RNA (1 mg) was reverse transcribed using 1.5 mlo fa
10 mM mix solution of random hexanucleotides (experiment 1) or
short specific RT primers (experiment 2), 10 mM dNTP mix,
0.1 M DTT, 40 units RNaseOUT and 200 units SuperScript
TM
III. Denaturation was performed at 90uC for 5 min. RT reaction
was carried out by 5 min at 38uC, 30 min at 42uC, 30 min at
55uC, in a final reaction volume of 20 ml. Realtime PCR reaction
was carried out in a final volume of 20 ml, containing 5 ml of using
cDNA (diluted 1:10), 20 mM each of specific primers, and 16
SYBR green PCR Master Mix (Applied Biosystems). To
determine the linear range and sensitivity of each assay, a
standard curve was generated using a serial 10-fold dilution of
pooled cDNA derived from all subjects. All experiments are
performed in duplicate and include a non-RT and no template
control. Reactions were run on Mx3005p (Strategene, La Jolla,
CA, USA) with cycling conditions: 95uC for 10 min, 40 cycles
95uC for 15 sec and 60uC for 1 min and followed by a melting
curve cycle; 95uC for 1 min, 55uC for 30 sec, 95uC for 30 sec.
Primer specificity was verified by a single peak in the melting curve
analysis and a single band of the right size on gel electrophoresis
for the all genes analyzed. Short RT primers: Dicer (TM 40.2
C) TTGGTGGACCAA; Drosha (TM 39 C) CGTCCAAA-
TAACTG; DGCR8 (TM 43.6 C) ACGTCCACGGT; U6 (TM
36.2 C) TATGGAACGCTT; U44 (TM 37.2 C) CAGTTA-
GAGC TAATT; PRI-155 (TM 41.9 C) ACAGCCTACAGC;
PRI-494 (TM 37.7 C) TCAAAACAGA ACTG. qPCR Prim-
miRNA and Depression
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GCT, Reverse: TTGGTGGACCAACAATGGAGG. DROSHA
(64 bp) Forward: AAGCGTTAATA GGAGCTGTTTACT,
Reverse: CGTCCAAATAACTGCTTGGCT. DGCR8 (92 bp)
Forward: GCTGAGGA AAGGGAGGAG, Reverse: ACGTC-
CACGGTGCACAG. U6 (95 bp) Forward: CTCGCTTCGG-
CAGCACA, Reverse: AACGCTTCACGAATTTGCGT. U44
(48 bp) Forward: TGATAGCAAATGCTGACTGA, Reverse:
CAGTTAGAGCTA ATTAAGACC. Pri-155 (135 bp) Forward:
CCAGCTTTATAACCGCATGT, Reverse: ACAGCCTACAG-
CAAGC CTTC. Pri-494 (134 bp) Forward: TGACTTCCCAA
AAGCAACCT, Reverse: TCAAAACA GAACTGCCGAATC.
Results
Global analysis of miRNA expression
The multiplex RT-PCR plate assayed 367 miRNAs in parallel,
of which 196 miRNAs exhibited mean expression values at least 2-
fold greater than the threshold for detectability (i.e., mean Ct value
#34 before normalization) in the control group. This set of 196
miRNAs was analyzed further. The complete set of normalized Ct
values is included as Supporting Information (File S1).
First, miRNA expression values were normalized relative to the
small RNA U6; this appears to be a suitable normalizer since U6
showed no significant mean difference across groups and exhibited
Table 2. microRNAs down-regulated in depressed suicide as determined by individual tests of statistical significance.
% of control p-value chromosomal locus 59 seed (2–8) Validated targets (miRecords)
hsa-miR-142-5p 0.635 0.0086 17q22 auaaagu
hsa-miR-137 0.744 0.0113 1p21.3 uauugcu CDK6, E2F6, NCOA2
hsa-miR-489 0.496 0.0113 7q21.3 ugacauc
hsa-miR-148b 0.735 0.0113 12q13.13 cagugca DNMT3B
hsa-miR-101 0.723 0.0129 1p31.3 (101-1), 9p24.1 (101-2) acaguac EZH2, MYCN, ICOS
hsa-miR-324-5p 0.667 0.0129 17p13.1 gcauccc
hsa-miR-301a 0.721 0.0129 17q22 agugcaa
hsa-miR-146a 0.772 0.0129 5q33.3 gagaacu
hsa-miR-335 0.764 0.0148 7q32.2 caagagc SOX4, PTPRN2, MERTK
hsa-miR-494 0.535 0.0174 14q32.31 gaaacau
hsa-miR-20b 0.704 0.0245 Xq26.2 aaagugc VEGFA
hsa-miR-376a* 0.768 0.0277 14q32.31 uagauuc SLC16A1, SFRS11, TTK
hsa-miR-190 0.715 0.0277 15q22.2 gauaugu
hsa-miR-155 0.526 0.0277 21q21.3 uaaugcu AGTR1, BACH1, LDOC1, MATR3, TM6SF1
hsa-miR-660 0.811 0.0277 Xp11.23 acccauu
hsa-miR-130a 0.764 0.0352 11q12.1 agugcaa TAC1, CSF1, MAFB, MEOX2, HOXA5
hsa-miR-27a 0.73 0.0352 19p13.12 ucacagu SP1, SP3, SP4
hsa-miR-497 0.724 0.0395 17p13.1 agcagca
hsa-miR-10a 0.512 0.0395 17q21.32 acccugu HOXA1
hsa-miR-20a 0.768 0.0442 13q31.3 aaagugc VEGFA, E2F1, RUNX1
hsa-miR-142-3p 0.642 0.0495 17q22 guagugu
microRNAs decreased by 30% or more (but p.0.05)
hsa-miR-211 0.595 0.2274 15q13.3 ucccuuu
hsa-miR-511 0.598 0.3318 10p12.33 ugucuuu
hsa-miR-424 0.604 0.1626 Xq26.3 agcagca NFIA
hsa-miR-369-3p 0.619 0.0759 14q32.31 auaauac
hsa-miR-597 0.628 0.0615 8p23.1 gugucac
hsa-miR-496 0.649 0.2274 14q32.31 gaguauu
hsa-miR-517c 0.658 0.1773 19q13.41 ucgugca
hsa-miR-184 0.665 0.1626 15q25.1 ggacgga
hsa-miR-34a 0.668 0.1359 1p36.23 ggcagug NOTCH1, DLL1, BCL2, E2F3, VEGFA, MYCN
hsa-miR-34b-5p 0.672 0.0557 11q23.1 aggcagu VEGFA
hsa-miR-24-1* 0.675 0.1089 9q22.32 gccuacu
hsa-miR-594 0.681 0.554 derived from tRNA
hsa-miR-34c-5p 0.682 0.2553 11q23.1 ggcagug
hsa-miR-17* 0.686 0.2659 13q31.3 cugcagu
hsa-miR-545 0.7 0.1337 Xq13.2 cagcaaa
hsa-miR-565 0.7 0.1024 derived from tRNA
doi:10.1371/journal.pone.0033201.t002
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significantly down-regulated (none up-regulated) at p=0.05. This
is a large and consistent response; note that one would expect to
observe only 5 miRNAs down-regulated and 5 miRNAs up-
regulated by chance alone, at p=0.05. Similarly, 24 miRNAs
were down-regulated but none up-regulated by 30% or more (i.e.,
delta Ct.0.5). The results were even more striking when SAM
analysis (Significance Analysis of Microarrays, Stanford Universi-
ty) was carried out: 100 miRNAs were identified as significantly
decreased at p=0.05 or better, with a false-discovery rate of
2.45% (i.e., fewer than 3 miRNAs would be expected to be
significant by chance alone).
In large part, this down-regulation is due to a general, global
down-regulation of miRNAs levels in the depressed suicide group.
In almost every case, the mean abundance of a given miRNA in
the depressed group was lower than its mean abundance in
controls (17% decrease on average). This finding was highly
significant (p=4.5610
243). Furthermore, this global down-regu-
lation was also apparent when the data were normalized instead to
the geometric mean of U6, U44 and U48 (p=8.3610
221). Finally,
to make sure that the apparent finding was not due to an up-
regulation of small RNAs in the depressed group, we examined the
15 samples in each group that had mir-122a spiked-into samples as
an exogenous control (mir-122a levels showed no difference across
groups). We still observed a highly significant global downregu-
lation of miRNA levels in the depressed group (p=1610
26).
Because the depressed group might be expected to be
heterogeneous in terms of underlying etiologies or other variables,
we hypothesized that the measured miRNA values in the
depressed group might an overall increased extent of heterogeneity
relative to the control group. However, by plotting the relation
between the standard deviation and the mean expression value
across all expressed miRNAs, we found that the miRNA
expression in the depressed suicide group was significantly less
variable than in the control group (Fig. 1).
Analysis of individual down-regulated miRNAs
Using data normalized to U6, twenty-one miRNAs were
significantly decreased (none were increased) when tested
individually at p=0.05 or better (Table 2). The majority of these
were also significant when the data were normalized instead to the
geometric mean of U6, U44 and U48 (data not shown). To
examine whether confounding variables had any effect on the
expression of individual miRNA, we performed correlational
analysis using Pearson product-moment analysis. We did not find
any effect of age, PMI, gender or pH of the brain on the
expression of miRNAs (data not shown).
The 21 down-regulated miRNAs include many miRNAs that
have been implicated in cellular growth and differentiation. The
set comprises both very abundant and low-abundance miRNAs,
and those with high and low synaptic enrichment as studied in
mouse homologues [29]; the miRNAs arise from both intronic and
intergenic loci, and are located on numerous chromosomes. An
additional 16 miRNAs were decreased by 30% or more that failed
to meet the criterion for significance (Table 2). This may be due,
at least in part, to their much lower expression – only 3 of 16
miRNAs in the non-significant set were abundantly expressed (i.e.,
mean Ct value,30), vs. 18 of 21 miRNAs in the significant set.
Nevertheless, because many of the non-significant miRNAs shared
chromosomal loci, 59-seeds, and predicted targets with the
significant miRNAs, they were also included in the analysis.
Almost half of the combined down-regulated miRNAs are
encoded at chromosomal loci near another miRNA on the list
(Table 2) and are possibly transcribed by the same primary
miRNA gene transcripts [32,35]: a) mir-142-5p and 142-3p; b)
mir-494, 376a*, 496, and 369-3p; c) mir-23b, 27b and 24-1*; d)
mir-34b* and 34c; and e) mir-17* and 20a. In addition, three pairs
of miRNAs are encoded at distances greater than 100 kb but still
lie within the same chromosomal region: a) mir-424 and 20b at
Xq26.2-3, 377 kb apart; b) mir-142 and 301a at 17q22, 820 kb
apart; and c) mir-324-5p and 497 at 17p13.1, 205 kb apart. This
Figure 1. Plot of Mean vs standard deviation (SD) for normal control and depressed suicide groups. miRNA expression in the depressed
suicide group is significantly less variable than in the control group.
doi:10.1371/journal.pone.0033201.g001
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expression is due to decreased transcription.
Many of the down-regulated miRNAs also shared 59-seed
sequences (particularly bases 2–8, Table 2) that are involved in
target recognition [36]. For example, identical seed sequences are
shared by a) mir-20a and 20b; b) mir-301a and 130a; and c) mir-
424 and 497. As well, a 6-mer nucleotide motif is shared by mir-
34a, 34b* and 34c, and strikingly, a 5-mer motif (AGUGC) within
the 59-seed is shared by 5 of the affected miRNAs (mir-148b, 301a,
130a, 20a, 20b) that is predicted to bind Alu sequences within the
39-UTR region of target mRNAs [37]. This suggests that the
down-regulated miRNAs should exhibit extensive overlap among
their mRNA targets.
Target Analysis
At the time that the analysis was carried out, 42 experimentally
validated targets were currently known for miRNAs in the down-
regulated set, according to curated data compiled at the
miRecords server [38], http://mirecords.umn.edu/miRecords/,
though it should be noted that validation experiments were
generally conducted in non-neural systems. Many of these are
transcription factors (e.g., E2F1, E2F6, BACH1, SP1, HOXA5,
RUNX1) and other nuclear proteins, but include transmembrane
and signaling proteins as well. Intriguingly, 4 different down-
regulated miRNAs all target the same validated growth factor,
VEGFA (mir-20b, 20a, 34a, 34b*), a molecule implicated in
depression in both humans and animal models (see Discussion).
Other validated targets include BCL2 (mir-34a), DNMT3B (mir-
148b), and MYCN (mir-101, 34a).
Among predicted targets, estrogen receptor alpha, ESR1, was
predicted to be targeted by 3 different down-regulated miRNAs
(mir-148b, 301a, 496). Others targeted by 3 or more affected
miRNAs include ubiquitin ligases (UBE2D1 and UBE2W), signal
transduction mediators (CAMK2G, AKAP1), the splicing factor
NOVA1 that regulates brain-specific alternative splicing; the
GABA-A receptor sub-unit GABRA4; calcium channel CAC-
NA1C; and brain-active transcription factors including SMAD5,
MITF, BACH2, MYCN, and ARID4A. Several of these
predicted targets interact with validated targets; for example,
ARIA4A binds E2F1; SMAD5 binds RUNX1; and estradiol
treatment decreases E2F1 levels in prefrontal cortex [39].
BACH2 transcription factor binding sites have been identified
upstream of many brain-expressed miRNAs [40]. Retinoblasto-
ma binding protein 1 (ARIA4A) is of interest because it recruits
histone deacetylases and regulates gene expression via chromatin-
based silencing.
We measured protein levels of several selected target proteins
implicated in depression (DMNT3b, VEGFA, and BCL2) in all
individuals by Western blotting (normalizing values using beta-
acting immunoreactivity). Whereas mean levels of DMNT3b was
strongly up-regulated (2.4-fold) in the depressed suicide group
(p=1610
211), VEGFA showed no significant change (1.03-fold,
p=0.4) and BCL2 was strongly down-regulated (0.57 of control,
p=2.4610
214)( Fig. 2). Changes in mean expression levels may
reflect a variety of influences (e.g. transcription factor activity and
differential turnover), as well as possible exerting regulatory
effects by miRNAs listed in Table 2 and others. When we
calculated the correlations between miRNA abundance and
protein abundance across individual samples within the control
group and (separately) within the depressed suicide group,
surprisingly, DNMT3b levels showed an extremely strong
positive correlation with mir-148b across individuals (r=0.91 in
controls, r=0.94 in the depressed suicide group). Similarly,
BCL2 was strongly and positively correlated with mir-34a
(r=0.92 in controls, r=0.82 in the depressed suicide group).
These findings strongly suggest that these miRNAs are likely to be
actively co-regulated with their targets, as often observed in brain
[7]. In contrast, VEGFA showed a mix of smaller positive and
inverse correlations: (mir-20a: r=0.08 in controls and r=0.26 in
depressed; mir-20b: r=0.34 in controls and r=0.24 in depressed;
mir-34a: r=0.34 in controls and r=20.39 in depressed; mir-
34b-5p: r=20.363 in controls and r=0.08 in depressed). Of
these, mir-34a is probably the most interesting finding, since the
correlation was positive in controls but inverse in the depressed
suicide group. This may reflect a reorganization of miRNA-target
networks (see below).
Quantile rank analysis of miRNA expression
Quantile rank analysis is a non-parametric technique that
identifies miRNAs which change their expression significantly
relative to the other miRNAs in the population. This is an
important parameter since different miRNAs often compete for
binding to RISC complexes, and therefore changes in quantile
rank may be as (or more) relevant for miRNA functional effects as
absolute changes in miRNA abundance across groups. The
miRNAs in each group were rank-ordered according to their
mean expression levels (i.e., were assigned quantile ranks), and we
then looked for miRNAs that show significant changes in quantile
rank across groups. Overall, changes in quantile rank were
relatively small and normally distributed (mean change=0,
SD=3.6). Although six miRNAs showed a relative increase in
quantile ranks relative to other miRNAs in the population
(Table 3), this finding is not different from what would be
expected by chance alone (expected number at p,0.05 or
better=5.3, observed=6). In contrast, ten miRNAs showed a
relative decrease in quantile ranks in excess of what is expected by
chance (expected number at p,0.05 or better=5.3, ob-
served=10) (Table 3). Most of these miRNAs were also listed
in Table 2, and may be regarded as especially likely to exert
functional effects in the depressed suicide group.
Figure 2. Protein levels of DNMT3b, BCL2, and VEGFA in PFC of
depressed suicide (n=18) and normal control (n=17) subjects.
Protein samples from tissue lysates were subjected to 10% polyacryl-
amide gel electrophoresis and transferred to enhanced chemilumines-
cence–nitrocellulose membranes, which were then incubated with
primary antibody specific for DNMT3b, BCL2, VEGFA or b-actin and
corresponding secondary antibody. The suicide group was compared
with the control group. DMNT3b was strongly up-regulated (2.4-fold) in
the depressed suicide group (
ap=1 610
211), VEGFA showed no
significant change (1.03-fold,
bp=0.4) and BCL2 was strongly down-
regulated (0.57 of control,
cp=2.4610
214). C=Controls; DS=Depressed
suicide.
doi:10.1371/journal.pone.0033201.g002
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Another complementary method of analyzing the miRNA
expression data is to identify pairs of miRNAs that are co-
regulated in their expression, up or down, across individuals within
a single group. The pairwise correlations for all miRNAs were
computed separately within the control group and within the
depression group. We were particularly interested in identifying
miRNA pairs that showed no significant correlation in the control
group, yet did exhibit a significant positive correlation in the
depressed group. This phenomenon allows one to detect
coordinated changes in the underlying driving forces for
expression (e.g., due to changes in transcription factors or miRNA
processing) in the depressed suicide group.
In this analysis, the list of miRNAs was first filtered to include
only those miRNAs that had robust expression (i.e., whose Ct
value ,35 in all individuals in both control and depressed groups).
The Ct values for each miRNA were normalized to the global
mean Ct value of the same individual (averaged over all miRNAs),
in order to remove correlations due to inter-individual differences
in overall miRNA content. Next, all miRNAs were examined pair-
wise and the Pearson correlation coefficient was computed for
each group separately. (Note that for n=17 subjects per group,
only correlations of r=0.5 or greater are significantly different
from 0 at p=0.05.) Finally, we identified pairs of miRNAs that
satisfied the following criteria: 1. They exhibited a significant
positive correlation in the depressed group (r-dep.0.5), but no
significant correlation (positive or negative) in the control group
(20.5 ,r-control#0.2). 2. The correlation coefficients in the
control group were much lower than in the depressed suicide
group (r-dep minus r-control .0.75).
This procedure revealed a set of 29 miRNAs, none of whom
were pairwise correlated in the normal control group, but which
formed a very extensive inter-connected network in the depressed
group (Fig. 3a). Several of the miRNAs (let-7b, mir-132, 181b,
338-3p, 486-5p, and 650) were ‘‘hubs’’ correlated with four to nine
other miRNAs in the network. Only two of the miRNAs were
significantly down-regulated in the depressed group (mir-142-5p
and 146a, neither of them hubs). Of the network miRNAs, mir-
181b was reported to be upregulated in schizophrenia [14], and
mir-132 and 134 are known to be CREB-regulated and involved
in neurite growth and dendritic spine growth, respectively [41,42].
Thus, correlation analysis revealed the existence of factors that
drive co-expression of a group of miRNAs across individuals
specifically in the depressed group (Fig. 3a). A similar analysis also
revealed a smaller set of miRNAs that were pairwise correlated in
the control group but NOT in the depressed suicide group
(Fig. 3b).
Expression of dicer, drosha and DGCR8 mRNA and
selected pri-miRs
Three genes involved in miRNA biogenesis (dicer, drosha and
DGCR8) were measured in the entire cohort using RT-PCR,
Figure 3. Network of microRNAs pairs in normal control and depressed groups. A. Network of microRNA pairs that showed no significant
correlation in the normal control group yet did exhibit a significant positive correlation in the depressed suicide group. See text for details. B.
Network of microRNA pairs that showed significant positive correlations in the normal control group yet were not correlated in the depressed suicide
group. See text for details.
doi:10.1371/journal.pone.0033201.g003
Table 3. Quantile rank analysis of miRNA expression data.
P Observed up Observed down
,0.05 mir-99b, 375, 462, 639 mir-142-5p, 155, 211, 489, 494, 594, 597
,0.02 mir-429, 642 mir-142-3p, 324-5p, 515-3p
doi:10.1371/journal.pone.0033201.t003
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measurements (Table 4). No significant difference was observed
between the control and depressed groups for any of these mRNAs
(Table 4). Two of the significantly down-regulated miRNAs were
also examined, that are encoded by single primary transcripts at
intergenic loci. Pri-miR-155 levels showed a 19% decrease in the
depressed group, but the finding was not statistically significant
(p=0.30; Table 4). Pri-miR-494 showed a 18% increase in the
depressed group, but this did not achieve significance either
(p=0.088).
Discussion
This study was designed to examine whether miRNA expression
is altered in postmortem prefrontal cortex of depressed suicide
subjects compared to matched control subjects who died from
natural or accidental causes. We observed that miRNA expression
was globally down-regulated in depressed suicide subjects, by 17%
on average, a finding that has extremely high statistical
significance. Global miRNA alterations have been reported in
other neuropsychiatric conditions. Notably, Beveridge et al.
[14,15] reported that overall miRNA expression is elevated to a
similar extent in samples of postmortem superior temporal and
prefrontal cortex in patients with schizophrenia. The elevated
miRNA expression was correlated with up-regulation of dicer,
drosha, and especially DGCR8 mRNA levels [15,43], although
these findings have not yet been replicated by other groups.
Sadikovic has emphasized that the RNAs commonly used to
normalize miRNA data (U6, U44 and U48) are very sensitive to
post-mortem decay and must be carefully matched across groups
to avoid the artifactual appearance of global shifts in miRNA
expression [44]. This potential artifact was ruled out in the present
study, because U6 used as normalizer showed equal expression
and low variance in both groups. Moreover, the use of spike-in
synthetic RNAs in our samples confirmed the global down-
regulation.
Such changes in miRNA levels are unlikely to be produced by
alterations in tissue composition or changes in cellular compart-
ments (e.g. loss of glial cells, neuronal shrinkage, or loss of
dendritic spines). At the molecular level, these findings might be
explained by one or more of the following responses: a) decreased
transcriptional or epigenetic repression of primary miRNA gene
transcripts, b) alterations in miRNA processing (e.g., by dicer,
phospho-TRBP, drosha, DGCR8, etc.), c) alterations in level of
Argonaute homolog proteins, or d) accelerated turnover of
miRNAs. Altered miRNA processing has been described in
various forms of cancer and in several cases, levels of dicer,
drosha correlate with tumor type and clinical outcome [45,46].
Changes in Argonaute protein levels can also cause global changes
in miRNA expression [41]. Because our data do not show
significant changes in mRNA levels of dicer, drosha or DGCR8,
and we did not observe significant changes in several selected pri-
miRs, further studies are needed to understand the molecular
mechanisms involved in the current situation.
As well, the functional implications of global miRNA shifts
have not been well studied and may vary depending on the
biological context. For example, if RISC binding sites are limiting
for gene targeting, then individual miRNAs will compete among
themselves for RISC binding sites and hence for regulating their
targets. A uniform decrease in abundance of the entire miRNA
population may, if large enough, create a new situation in which
RISC binding sites are now in excess. This might render each
miRNA molecule more effective, despite their overall reduced
numbers.
Both the global decrease of miRNA expression and its lower
variability are consistent with hypo-activation of the frontal cortex,
which has been reported in depressed subjects [47,48,49,50]. In a
previous study, we found a global increase in miRNA expression
that accompanied learning in inbred C57BL/6J mice [19]. The
miRNAs which showed the largest changes across groups tended
to show high inter-individual variability within groups (both in the
discrimination learning group and in the pseudo-training control
group). This suggests that the inter-individual variability of
miRNA expression values is not simply random noise, but reflects
the fact that at least some miRNAs are biologically responsive to a
variety of environmental, sensory and/or contextual cues even in
the control animals. It is pertinent to mention that in a recent
preliminary study, we found that the expression of miRNAs is
downregulated in frontal cortex of rats treated with corticosterone
(Dwivedi et al., unpublished data). Some of these miRNAs were
similar to those observed in prefrontal cortex of depressed suicide
subjects, suggesting the possibility that stress might be one of the
factors regulating expression of miRNAs in depressed subjects.
Among targets that have been experimentally validated
(Table 2) and that are co-expressed in prefrontal cortex, at least
three (VEGFA, BCL2, and DNA methyltransferase 3B) have been
previously implicated in depression or suicide [51,52,53]. Of
miRNAs that showed the largest and most robust changes in
depressed subjects, predicted targets included several brain-active
transcription factors such as MITF, SMAD5, MYCN, estrogen
receptor alpha (ESR1) and BACH2. MITF and BACH2
transcription factor binding sites have been identified upstream
of many brain-expressed miRNAs [40]. The splicing factor
NOVA1 that regulates brain-specific alternative splicing was
predicted to be hit by 4 different down-regulated miRNAs. Several
presynaptic and postsynaptic proteins important for neurotrans-
mission or synaptic plasticity were also predicted targets: VEGF
receptor Neuropilin-1 (NRP1), GAP43, SNAP25, synaptojanin-1,
synaptotagmin-1, and LIM kinase-1. VEGFA is a growth factor
implicated in depression in both humans and animal models.
VEGFA treatment upregulates nuclear expression of E2F1,
another validated target, among other cell cycle-related genes
[54]. In addition, a variety of signaling proteins, ion channels, and
ubiquitin ligases were also identified. Several of these predicted
targets have been linked to affective disorders. As well, several of
the down-regulated miRNAs may also interact with targets in a
variety of unconventional ways [55,56]: for example, mir-10a can
enhance translation of 59-TOP proteins responsible for regulating
Table 4. Levels of Dicer, Drosha and DGCR8 mRNA are similar
in depressed suicide subjects and normal controls.
Experiment 1 Experiment 2
% control mean p-value % control mean p-value
Dicer 78 0.26 107 0.67
Drosha 90 0.62 88 0.18
DGCR8 106 0.75 97 0.76
Pri-miR-155 81 0.3
Pri-miR-494 118 0.088
Experiment 1: RT step carried out using random hexanucleotide primers.
Experiment 2: RT step carried out using gene specific primers. Data were
normalized using U44, and p-values were calculated using t-test, 2-tailed,
unpaired. None of the comparisons were statistically significant at p=0.05
(paired test gave similar results).
doi:10.1371/journal.pone.0033201.t004
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of the nearby PSD95 gene and may affect its transcription [58].
The second major finding of our study is that miRNA pathways
are not simply down-regulated in the depressed group, but are also
dramatically reorganized in a coordinated fashion. A set of 29
miRNAs was identified whose expression was not correlated at all
with each other in the control group, but which formed a highly
correlated network in the depressed group (Fig. 3a). Most of these
miRNAs showed no significant change in mean expression levels
across groups. Such a network is likely to reflect the influence of
shared factor(s) which regulate the miRNAs in depressed suicide
subjects, e.g., transcription factors or proteins involved in the
miRNA processing pathway that regulate specific subsets of
miRNAs [59].
The miRNA co-expression analysis complemented our separate
analysis of how miRNA levels correlated with protein abundance
of their predicted targets (DMNT3b, VEGFA BCL2) across
individuals. There was no simple global change in target
abundance – rather, DMNT3b was strongly up-regulated in the
depressed suicide group, whereas BCL2 was down-regulated and
VEGFA was unchanged. Several miRNAs showed a strong
positive correlation with DMNT3b and BCL2, instead of the
inverse correlation that would be expected if the miRNAs simply
inhibited translation of their protein targets. These miRNAs
appear to be co-regulated with their targets, a phenomenon that is
commonly observed in brain [7] and that, again, emphasizes the
importance of considering the entire miRNA – mRNA network
and cellular context when interpreting the likely effects of changes
in miRNA abundance.
Preliminary studies in our laboratory have measured miRNA
expression in prefrontal cortex (BA10) postmortem samples
provided by the Stanley Neuropathology Consortium, consisting
of 15 controls, 15 depressed, 15 bipolar and 15 schizophrenic
subjects. About half of the psychiatric patients died of suicide
across the diagnostic categories. We observed a significant global
down-regulation of miRNA expression when all suicide (n=20) vs.
all non-suicide (n=40) subjects are compared regardless of
diagnosis (ms., in preparation).
In conclusion, measurements of miRNAs can substantially
contribute to our understanding of how gene expression networks
are reorganized in depression and/or suicide. We do not know if
specific miRNAs are independent risk factors or if the down-
regulation of miRNAs precedes the onset of symptomatology, yet
the network of down-regulated miRNAs certainly regulates genes
that participate in pathogenesis. The present report is a discovery
study that needs replication, and in the future, it will be interesting
to examine the cell types and subcellular distribution of the
affected miRNAs, additional brain regions, and other types of
mood disorders.
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